Telix Pharmaceuticals to Acquire European Production Facility

MELBOURNE (Australia) and BRUSSELS (Belgium) – Oct. 3, 2019 - Telix Pharmaceuticals Ltd is pleased to announce that it has entered into a conditional purchase agreement with Eckert & Ziegler Strahlen

MELBOURNE (Australia) and BRUSSELS (Belgium) – Oct. 3, 2019.

Telix Pharmaceuticals Ltd is pleased to announce that it has entered into a conditional purchase agreement with Eckert & Ziegler Strahlen and Medizintechnik Aktiengesellschaft to acquire a licensed radiopharmaceutical production facility in Seneffe, Belgium.

To read the full media release click here.